ADVANCES IN ETHER PHOSPHOLIPIDS TREATMENT OF CANCER

被引：25
作者：
PRINCIPE, P
BRAQUET, P
机构：
[1] Institut Henri Beaufour, 91952 Les Ulis Cedex
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 1995年 / 18卷 / 03期
关键词：
D O I：
10.1016/1040-8428(94)00118-D
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：155 / 178
页数：24
相关论文
共 174 条
[1]  
ALUNNIBISTOCCHI G, 1990, FARMACO, V45, P499
[2]  
Andreesen R, 1988, Prog Biochem Pharmacol, V22, P118
[3]  
ANDREESEN R, 1988, NEW TRENDS LIPID MED, V1, P16
[4]   AN ANTAGONIST TO PLATELET ACTIVATING FACTOR COUNTERACTS THE TUMORICIDAL ACTION OF ALKYL LYSOPHOSPHOLIPIDS [J].
BAZILL, GW ;
DEXTER, TM .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (02) :374-377
[5]  
BAZILL GW, 1990, CANCER RES, V50, P7505
[6]  
BERDEL WE, 1987, ANTICANCER RES, V7, P1181
[7]   MEMBRANE-INTERACTIVE LIPIDS AS EXPERIMENTAL ANTICANCER DRUGS [J].
BERDEL, WE .
BRITISH JOURNAL OF CANCER, 1991, 64 (02) :208-211
[8]  
BERDEL WE, 1992, ONKOLOGIE, V15, P238
[9]  
BERDEL WE, 1985, PHOSPHOLIPIDS CELLUL, V2, P41
[10]  
BERDEL WE, 1987, PLATELET ACTIVATING, P449
12345678910